Home » Aveo Receives Milestone Payment From Biogen
Aveo Receives Milestone Payment From Biogen
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing
and commercializing cancer therapeutics, Wednesday announced it has received a $5 million milestone payment from Biogen Idec International GmbH … for
the selection of the first humanized antibody development candidate from its ErbB3 program.
Forbes
Forbes
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May